Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
10/14/2010 | US20100260763 Polypeptides, antibody variable domains and antagonists methods for |
10/14/2010 | US20100260752 Opsonic and protective antibodies specific for lipoteichoic acid of gram positive bacteria |
10/14/2010 | US20100260743 Solubilization and Targeted Delivery of Drugs With Self-Assembling Amphiphilic Polymers |
10/14/2010 | US20100260720 Prevention of opportunistic infections in immune-compromised subjects |
10/14/2010 | US20100260717 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection |
10/14/2010 | US20100260715 Hepatitis c virus inhibitors |
10/14/2010 | US20100260713 Compositions and Methods for the Inhibition of Hepatitis C Viral Replication with Structural Analogs |
10/14/2010 | US20100260712 Use of human antibody capable of neutralizing hepatitis b virus for the prevention or treatment of hepatitis b virus infection |
10/14/2010 | US20100260711 3-aminosulfonyl substituted indole derivatives and methods of use thereof |
10/14/2010 | US20100260710 Macrocyclic serine protease inhibitors |
10/14/2010 | US20100260709 Organic compounds and their uses |
10/14/2010 | US20100260708 Hepatitis C Virus Inhibitors |
10/14/2010 | US20100260706 Compositions and methods for improving production of recombinant polypeptides |
10/14/2010 | US20100260704 Human interferon-gamma (infgamma) variants |
10/14/2010 | US20100260687 Personal care compositions including polyurethane dispersions |
10/14/2010 | DE102009015917A1 Use of an active agent comprising resveratrol, thymol, xanthohumol or vitamin C for inhibition and/or prophylaxis of e.g. eryptosis, acute renal failure, anemia, shock, atherosclerosis, thrombosis, diabetes mellitus and sickle cell anemia |
10/14/2010 | CA2758365A1 Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (hiv) or hepatitis c |
10/14/2010 | CA2758149A1 Inhibitors of hiv replication |
10/14/2010 | CA2758146A1 Organic compounds and their uses |
10/14/2010 | CA2758072A1 Macrocyclic serine protease inhibitors |
10/14/2010 | CA2758047A1 Hepatitis c virus inhibitors |
10/14/2010 | CA2757963A1 Hepatitis c virus inhibitors |
10/14/2010 | CA2757828A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection |
10/14/2010 | CA2757640A1 Indole derivatives and methods for antiviral treatment |
10/14/2010 | CA2757574A1 Inhibitors of bacterial type iii secretion system |
10/14/2010 | CA2757269A1 Hepatitis c virus inhibitors |
10/14/2010 | CA2756727A1 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity |
10/14/2010 | CA2756104A1 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action |
10/14/2010 | CA2753151A1 Substituted piperidines as ccr3 antagonists |
10/13/2010 | EP2238980A1 Aqueous compositions containing metronidazole |
10/13/2010 | EP2238253A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
10/13/2010 | EP2238142A2 Macrocyclic indoles as hepatitis c virus inhibitors |
10/13/2010 | EP2238138A1 Tricyclic nitrogen compounds and their use as antibacterial agents |
10/13/2010 | EP2238135A1 Naphthyridin-2(1h) -one compounds useful as antibacterials |
10/13/2010 | EP2237794A2 Chimeric hiv fusion proteins as vaccines |
10/13/2010 | EP2237769A2 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock animals |
10/13/2010 | EP2237684A2 Agonists for antimicrobial peptide systems |
10/13/2010 | EP1931358B1 Pharmaceutical combinations containing lamivudine, stavudine and nevirapine |
10/13/2010 | EP1783129B1 Spiropiperidyl rifamycins for the treatment of microbacterial infections |
10/13/2010 | EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
10/13/2010 | EP1480644B1 Novel heterocyclic compounds which are active as inhibitors of beta+lactamases |
10/13/2010 | EP1102848B1 Molecules designated ldcam |
10/13/2010 | CN201602811U 多功能缝线 Multifunction sutures |
10/13/2010 | CN201602500U 一种保健枕 One kind Pillow |
10/13/2010 | CN1939922B 5H-thiophene [3,4-C] pyrrole-4,6-diketone derivative for inhibiting cell release tumor necrosis factor |
10/13/2010 | CN1931258B Preparation process and use of loquat seed extract |
10/13/2010 | CN1927251B Medicament for animals with heat clearing and detoxicating functions and preparing method thereof |
10/13/2010 | CN1823890B Formula of oral Chinese medicine used for treating virus myocarditis |
10/13/2010 | CN1799586B Cold treating capsule and its preparation method |
10/13/2010 | CN1737147B Heat shock protein 65- multiple epitope hepatitis B virus core antigen recombinant protein (HSP65-HBcAg) |
10/13/2010 | CN1646473B Novel curcumin analogues and uses thereof |
10/13/2010 | CN1563088B Specific composite IgY for anti influenza and preparation |
10/13/2010 | CN101861330A Polypeptide compound |
10/13/2010 | CN101861300A Crystalline forms of tigecycline hydrochloride |
10/13/2010 | CN101857861A Molecular marker for immunological recognition and construction and application thereof |
10/13/2010 | CN101857841A Marine fungi aspergillus unguis strain, active extract thereof and preparation method and use of active extract thereof and active components thereof |
10/13/2010 | CN101857631A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
10/13/2010 | CN101857613A Rupestonic acid glycolipid derivative and preparation method and applications thereof |
10/13/2010 | CN101857564A Method for removing dioxane from Ftibamzone raw material |
10/13/2010 | CN101857562A Synthetic method of QseC ligand derivatives with role of inhibiting bacterial virulence |
10/13/2010 | CN101857540A Method for producing adipic acid, hexamethylenediamine hydrochloride and polyhexamethylene (di)guanidine chloride from nylon-66 through depolymerization |
10/13/2010 | CN101856498A Anti-septic shock medicine compound and application thereof |
10/13/2010 | CN101856495A Medical composition and mixture for treating chicken infectious bursal disease and preparation method thereof |
10/13/2010 | CN101856493A Compound piracetam brain protein hydrolysate tablet and preparation method thereof |
10/13/2010 | CN101856470A Chinese medicament for treating hepatitis B |
10/13/2010 | CN101856453A Nanomedicine composition for resisting primary bronchitis virus and preparation method thereof |
10/13/2010 | CN101856447A Capsule capable of clearing heat and purging fire |
10/13/2010 | CN101856421A Medicament for treating herpes zoster and preparation method thereof |
10/13/2010 | CN101856416A Chinese herbal medicament oral liquid for treating chicken colibacillosis |
10/13/2010 | CN101856402A Medicament composition for adjuvant treating hepatitis |
10/13/2010 | CN101856397A Medicinal composition for treating hepatitis B and preparation method thereof |
10/13/2010 | CN101856396A Dispersible tablet for treating hepatitis B and preparation method thereof |
10/13/2010 | CN101856376A Chinese medicament for treating dermatophytosis |
10/13/2010 | CN101856358A Medicinal composition for treating vaginitis |
10/13/2010 | CN101856356A Cefazedone sodium composition powder injection |
10/13/2010 | CN101856355A Therapeutical effect of atabrine and substitutes thereof on hepatitis B |
10/13/2010 | CN101856347A Extract of leontopodic acid plant and application of active ingredients thereof in treating hepatitis |
10/13/2010 | CN101856335A Azithromycin composite freeze-dried powder for injection |
10/13/2010 | CN101856333A Freeze-dried powder injection of cefamandole nafate and preparation method thereof |
10/13/2010 | CN101856332A Method for preparing 8, 9-single-epoxy brevifolin PLGA microspheres |
10/13/2010 | CN101856328A Ketoconazole foaming agent and preparation method thereof |
10/13/2010 | CN101856326A Method for preparing medical lycorine emulsion |
10/13/2010 | CN101856323A Beta-CD inclusion suppository containing rana chensinensis antibacterial peptide and preparation method thereof |
10/13/2010 | CN101530393B Clindamycin phosphate lipidosome freeze-dried preparation |
10/13/2010 | CN101502631B Synergistic medicament composition containing Aolamite and Chinese medicine extract |
10/13/2010 | CN101502589B Chinese and western medicinal composition containing bifendate for auxiliary treatment of hepatitis |
10/13/2010 | CN101502572B Auxiliary Chinese and western medicinal composition for treating hepatitis |
10/13/2010 | CN101502551B Synergistic composition containing bifendate |
10/13/2010 | CN101411717B Composition for treating acute enteritis and diarrhea |
10/13/2010 | CN101396371B Content determination method of Tibet crude-medicine processing material and new use thereof |
10/13/2010 | CN101361895B Traditional Chinese medicine combination for treating measles complicated pneumonia |
10/13/2010 | CN101333219B Penem derivates with mercapto pyrrolidine formamide benzene alkyl heterocycle |
10/13/2010 | CN101328178B Penem derivates containing thiophen substituted sulfhydryl pyrrolidine |
10/13/2010 | CN101323615B Pennem derivates containing formamide heterocycle sulfonic acid amide sulfhydryl pyrrolidine |
10/13/2010 | CN101317847B Medicament composition for eyes or nose, and uses thereof |
10/13/2010 | CN101280292B Virus velogen strain for porcine reproductive and respiratory syndrome, attenuated vaccine strain thereof and application thereof |
10/13/2010 | CN101279978B Separation and purification method of cefathiamidine and preparation of cefathiamidine power injection |
10/13/2010 | CN101275132B SiRNA capable of inhibiting influenza A virus replication and coding sequence thereof |
10/13/2010 | CN101245081B Novel cephalosporin derivative |
10/13/2010 | CN101244151B Medicament for treating dysentery |